Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

Go back to Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
(NASDAQ: ETON) Delayed: 57.68 --0 (-0%)
Previous Close $57.68    52 Week High $ 
Open $57.68    52 Week Low $ 
Day High $57.68    P/E N/A 
Day Low $57.68    EPS $ 
Volume 33